| VRTIX | VYSEX | VRTIX / VYSEX | |
| Total Expense Ratio | 0.05 | 0.82 | 6% |
| Annual Report Gross Expense Ratio | 0.05 | 0.82 | 6% |
| Fund Existence | 16 years | 13 years | - |
| Gain YTD | 22.079 | 17.189 | 128% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 1000000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.5B | 189M | 9,259% |
| Annual Yield % from dividends | 1.12 | 0.59 | 190% |
| Returns for 1 year | 33.16 | 13.37 | 248% |
| Returns for 3 years | 65.02 | 25.77 | 252% |
| Returns for 5 years | 41.82 | -5.55 | -753% |
| Returns for 10 years | 152.08 | 6.09 | 2,497% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MEDX | 37.54 | 0.53 | +1.44% |
| Horizon Kinetics Medical ETF | |||
| FDT | 95.24 | 0.67 | +0.71% |
| First Trust Dev Mkts Ex-US AlphaDEX® ETF | |||
| XDIV | 31.25 | 0.17 | +0.55% |
| Roundhill S&P 500 No Dividend Target ETF | |||
| ARMG | 31.95 | N/A | N/A |
| Leverage Shares 2X Long Arm Daily ETF | |||
| VXX | 18.95 | -0.24 | -1.25% |
| iPath® B S&P 500® VIX S/T Futs™ ETN | |||